Skip to main content
Terug
Watch Compare

BIOMERICA INC

Datakwaliteit: 100%
BMRA
Nasdaq Manufacturing Chemicals
€ 2,13
▼ € 0,02 (-0,90%)
Marktkapitalisatie: 6,49 M
Prijs
€ 2,15
Marktkapitalisatie
6,49 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -7,32% annually over 5 years
Negative free cash flow of -2,99 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,40%
Capital efficient — spends only 0,54% of revenue on capex

Groei

Revenue Growth (5Y)
-7,32%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-1,92%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-83,94%
Onder sectorgemiddelde (-53,47%)
ROIC-86,66%
Net Margin-90,31%
Op. Margin-118,08%

Veiligheid

Debt / Equity
N/A
Current Ratio3,25
Interest CoverageN/A

Waardering

PE (TTM)
-1,61
Onder sectorgemiddelde (-1,48)
P/B Ratio1,46
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -1,6 -1,5
P/B 1,5 1,6
ROE % -83,9 -53,5
Net Margin % -90,3 -41,5
Rev Growth 5Y % -7,3 1,8
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 1 kwartaal
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q12023 N/A -€ 0,96 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) -1,92% Revenue Growth (3Y) -0,26%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -7,32% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4,46 M Net Income (TTM) -4,03 M
ROE -83,94% ROA -62,46%
Gross Margin 5,63% Operating Margin -118,08%
Net Margin -90,31% Free Cash Flow (TTM) -2,99 M
ROIC -86,66% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,25
Interest Coverage N/A Asset Turnover 0,69
Working Capital 3,59 M Tangible Book Value 4,22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,61 Forward P/E N/A
P/B Ratio 1,46 P/S Ratio 1,46
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -46,05%
Market Cap 6,49 M Enterprise Value 3,95 M
Per Share
EPS (Diluted TTM) -2,51 Revenue / Share 1,48
FCF / Share -0,99 OCF / Share -0,98
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,54% FCF Conversion 74,26%
SBC-Adj. FCF -3,44 M Growth Momentum 5,40

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5,31 M 5,42 M 5,34 M 18,87 M 7,20 M
Net Income -4,97 M -5,98 M -7,14 M -4,53 M -6,47 M
EPS (Diluted) -2,16 -0,36 -0,50 -0,36 -0,54
Gross Profit 498.000,0 611.000,0 446.000,0 2,98 M 496.981,0
Operating Income -5,14 M -6,37 M -7,22 M -4,53 M -6,52 M
EBITDA — — — — —
R&D Expenses 1,02 M 1,49 M 1,58 M 1,81 M 2,41 M
SG&A Expenses 4,61 M 5,49 M 6,09 M 5,70 M 4,61 M
D&A 87.000,0 81.000,0 84.000,0 100.000,0 104.715,0
Interest Expense — — — 367,0 367,0
Income Tax 1.000,0 42.000,0 51.000,0 23.719,0 13.057,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5,95 M 9,25 M 14,45 M 11,37 M 11,82 M
Total Liabilities 1,84 M 2,66 M 2,73 M 3,05 M 2,59 M
Shareholders' Equity 4,11 M 6,59 M 11,72 M 8,32 M 9,23 M
Total Debt — — — — —
Cash & Equivalents 2,40 M 4,17 M 9,72 M 5,92 M 4,20 M
Current Assets 4,88 M 7,73 M 12,80 M 9,43 M 9,23 M
Current Liabilities 1,74 M 2,20 M 1,95 M 2,01 M 1,30 M